GCM
ANVS icon

Gallacher Capital Management’s Annovis Bio ANVS Stock Holding History

Gallacher Capital Management’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6K Hold
5,705
– – 0.01% 259
2026
Q1 		$12.7K Buy
+5,705
New +$15.6K ﹤0.01% 301

Other funds holding ANVS

SG
Sherry Group Mountain Home, Arkansas $102M AUM
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
DPW
DiNuzzo Private Wealth Beaver, Pennsylvania $1.01B AUM 16.94% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Gallacher Capital Management's ANVS Position: Q2 2026 in Review

Gallacher Capital Management held its Annovis Bio (ANVS) position steady in Q2 2026 at 5,705 shares worth $10.6K. The position accounts for 0.01% of the portfolio, ranked #259.

Gallacher Capital Management first reported a position in ANVS in Q1 2026 and has held it in 2 quarters since. The position peaked at $12.7K in Q1 2026. 7 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • Gallacher Capital Management held 5,705 shares of Annovis Bio worth $10.6K as of Q2 2026.
  • Gallacher Capital Management left its Annovis Bio share count unchanged in Q2 2026.
  • Annovis Bio made up 0.01% of Gallacher Capital Management's portfolio in Q2 2026, its #259 holding.
  • Gallacher Capital Management first reported a position in Annovis Bio in Q1 2026 and has held it in 2 quarters since.
  • Gallacher Capital Management's Annovis Bio position peaked at $12.7K in Q1 2026.
  • 7 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.